|
1.Brook RD, Rajagopalan S, Pope CA, 3rd, Brook JR, Bhatnagar A, Diez-Roux AV, Holguin F, Hong Y, Luepker RV, Mittleman MA, et al: Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation 2010, 121:2331-2378. 2.Dockery DW, Pope CA, 3rd, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Jr., Speizer FE: An association between air pollution and mortality in six U.S. cities. N Engl J Med 1993, 329:1753-1759. 3.Pope CA, 3rd, Thun MJ, Namboodiri MM, Dockery DW, Evans JS, Speizer FE, Heath CW, Jr.: Particulate air pollution as a predictor of mortality in a prospective study of U.S. adults. Am J Respir Crit Care Med 1995, 151:669-674. 4.Pope CA, 3rd, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, Thurston GD: Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA 2002, 287:1132-1141. 5.Hsieh YL, Yang YH, Wu TN, Yang CY: Air pollution and hospital admissions for myocardial infarction in a subtropical city: Taipei, Taiwan. J Toxicol Environ Health A 2010, 73:757-765. 6.Tsai SS, Chiu HF, Wu TN, Yang CY: Air pollution and emergency room visits for cardiac arrhythmia in a subtropical city: Taipei, Taiwan. Inhal Toxicol 2009, 21:1113-1118. 7.Bell ML, Levy JK, Lin Z: The effect of sandstorms and air pollution on cause-specific hospital admissions in Taipei, Taiwan. Occup Environ Med 2008, 65:104-111. 8.Ling SH, van Eeden SF: Particulate matter air pollution exposure: role in the development and exacerbation of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 2009, 4:233-243. 9.Gauderman WJ, Avol E, Gilliland F, Vora H, Thomas D, Berhane K, McConnell R, Kuenzli N, Lurmann F, Rappaport E, et al: The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med 2004, 351:1057-1067. 10.Clark NA, Demers PA, Karr CJ, Koehoorn M, Lencar C, Tamburic L, Brauer M: Effect of early life exposure to air pollution on development of childhood asthma. Environ Health Perspect 2010, 118:284-290. 11.Gehring U, Wijga AH, Brauer M, Fischer P, de Jongste JC, Kerkhof M, Oldenwening M, Smit HA, Brunekreef B: Traffic-related air pollution and the development of asthma and allergies during the first 8 years of life. Am J Respir Crit Care Med 2010, 181:596-603. 12.Sin DD, Wu L, Man SF: The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005, 127:1952-1959. 13.Andersen ZJ, Hvidberg M, Jensen SS, Ketzel M, Loft S, Sorensen M, Tjonneland A, Overvad K, Raaschou-Nielsen O: Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: a cohort study. Am J Respir Crit Care Med 2011, 183:455-461. 14.Franchini M, Mannucci PM: Particulate air pollution and cardiovascular risk: short-term and long-term effects. Semin Thromb Hemost 2009, 35:665-670. 15.Ghio AJ, Kim C, Devlin RB: Concentrated ambient air particles induce mild pulmonary inflammation in healthy human volunteers. Am J Respir Crit Care Med 2000, 162:981-988. 16.Gurgueira SA, Lawrence J, Coull B, Murthy GG, Gonzalez-Flecha B: Rapid increases in the steady-state concentration of reactive oxygen species in the lungs and heart after particulate air pollution inhalation. Environ Health Perspect 2002, 110:749-755. 17.Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL, Pepys MB, Koenig W: Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J 2001, 22:1198-1204. 18.Sharman JE, Coombes JS, Geraghty DP, Fraser DI: Exposure to automotive pollution increases plasma susceptibility to oxidation. Arch Environ Health 2002, 57:536-540. 19.Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R: Ambient pollution and heart rate variability. Circulation 2000, 101:1267-1273. 20.Pope CA, 3rd, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, Schwartz J, Villegas GM, Gold DR, Dockery DW: Heart rate variability associated with particulate air pollution. Am Heart J 1999, 138:890-899. 21.Park SK, O''Neill MS, Vokonas PS, Sparrow D, Schwartz J: Effects of air pollution on heart rate variability: the VA normative aging study. Environ Health Perspect 2005, 113:304-309. 22.O''Toole TE, Conklin DJ, Bhatnagar A: Environmental risk factors for heart disease. Rev Environ Health 2008, 23:167-202. 23.Simkhovich BZ, Kleinman MT, Kloner RA: Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. Journal of the American College of Cardiology 2008, 52:719-726. 24.Zhao J, Xie Y, Qian X, Jiang R, Song W: Acute effects of fine particles on cardiovascular system: differences between the spontaneously hypertensive rats and wistar kyoto rats. Toxicol Lett 2010, 193:50-60. 25.Xia T, Kovochich M, Nel AE: Impairment of mitochondrial function by particulate matter (PM) and their toxic components: implications for PM-induced cardiovascular and lung disease. Front Biosci 2007, 12:1238-1246. 26.Xu X, Liu C, Xu Z, Tzan K, Zhong M, Wang A, Lippmann M, Chen LC, Rajagopalan S, Sun Q: Long-term exposure to ambient fine particulate pollution induces insulin resistance and mitochondrial alteration in adipose tissue. Toxicol Sci 2011, 124:88-98. 27.Hou L, Zhu ZZ, Zhang X, Nordio F, Bonzini M, Schwartz J, Hoxha M, Dioni L, Marinelli B, Pegoraro V, et al: Airborne particulate matter and mitochondrial damage: a cross-sectional study. Environ Health 2010, 9:48. 28.Bino RJ, Hall RD, Fiehn O, Kopka J, Saito K, Draper J, Nikolau BJ, Mendes P, Roessner-Tunali U, Beale MH, et al: Potential of metabolomics as a functional genomics tool. Trends Plant Sci 2004, 9:418-425. 29.Dunn WB, Bailey NJ, Johnson HE: Measuring the metabolome: current analytical technologies. Analyst 2005, 130:606-625. 30.Feng J, Li X, Pei F, Chen X, Li S, Nie Y: 1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. Anal Biochem 2002, 301:1-7. 31.German JB, Hammock BD, Watkins SM: Metabolomics: building on a century of biochemistry to guide human health. Metabolomics 2005, 1:3-9. 32.Goodacre R, Vaidyanathan S, Dunn WB, Harrigan GG, Kell DB: Metabolomics by numbers: acquiring and understanding global metabolite data. Trends Biotechnol 2004, 22:245-252. 33.Rochfort S: Metabolomics reviewed: a new "omics" platform technology for systems biology and implications for natural products research. J Nat Prod 2005, 68:1813-1820. 34.Smolinska A, Blanchet L, Buydens LM, Wijmenga SS: NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 2012, 750:82-97. 35.Dunn WB, Broadhurst DI, Atherton HJ, Goodacre R, Griffin JL: Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem Soc Rev 2011, 40:387-426. 36.Fiehn O: Metabolomics--the link between genotypes and phenotypes. Plant Mol Biol 2002, 48:155-171. 37.Mamas M, Dunn WB, Neyses L, Goodacre R: The role of metabolites and metabolomics in clinically applicable biomarkers of disease. Arch Toxicol 2011, 85:5-17. 38.Quinn MT, Parthasarathy S, Fong LG, Steinberg D: Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 1987, 84:2995-2998. 39.Kuller L, Arnold A, Tracy R, Otvos J, Burke G, Psaty B, Siscovick D, Freedman DS, Kronmal R: Nuclear magnetic resonance spectroscopy of lipoproteins and risk of coronary heart disease in the cardiovascular health study. Arterioscler Thromb Vasc Biol 2002, 22:1175-1180. 40.Jung J, Kim SH, Lee HS, Choi GS, Jung YS, Ryu DH, Park HS, Hwang GS: Serum metabolomics reveals pathways and biomarkers associated with asthma pathogenesis. Clin Exp Allergy 2013, 43:425-433. 41.Liao Peiqiu WL, Wu Huifeng, Li Weisheng, Wu Yijie, Li Xiaojing, Ni Jiazuan, Pei Fenkui: Biochemical effects of gadolinium chloride in rats liver and kidney studied by 1H NMR metabolomics. Journal of rare earths 2008, 27. 42.Pan Z, Raftery D: Comparing and combining NMR spectroscopy and mass spectrometry in metabolomics. Anal Bioanal Chem 2007, 387:525-527. 43.Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK: Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2007, 2:2692-2703. 44.Howard BV: Acetate as a Carbon Source for Lipid-Synthesis in Cultured-Cells. Biochimica Et Biophysica Acta 1977, 488:145-151. 45.Goldberg RP, Brunengraber H: Contributions of cytosolic and mitochondrial acetyl-CoA syntheses to the activation of lipogenic acetate in rat liver. Adv Exp Med Biol 1980, 132:413-418. 46.Goodnight SH, Jr., Harris WS, Connor WE, Illingworth DR: Polyunsaturated fatty acids, hyperlipidemia, and thrombosis. Arteriosclerosis 1982, 2:87-113. 47.Ross R: Cell biology of atherosclerosis. Annu Rev Physiol 1995, 57:791-804. 48.Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM: Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009, 119:931-939. 49.Mora S, Otvos JD, Rosenson RS, Pradhan A, Buring JE, Ridker PM: Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes 2010, 59:1153-1160. 50.Treichel JL, Henry MM, Skumatz CM, Eells JT, Burke JM: Formate, the toxic metabolite of methanol, in cultured ocular cells. Neurotoxicology 2003, 24:825-834. 51.Nicholls P: Formate as an inhibitor of cytochrome c oxidase. Biochem Biophys Res Commun 1975, 67:610-616. 52.Du L, Su Y, Sun D, Zhu W, Wang J, Zhuang X, Zhou S, Lu Y: Formic acid induces Yca1p-independent apoptosis-like cell death in the yeast Saccharomyces cerevisiae. FEMS Yeast Res 2008, 8:531-539. 53.Lee HC, Wei YH: Mitochondrial biogenesis and mitochondrial DNA maintenance of mammalian cells under oxidative stress. Int J Biochem Cell Biol 2005, 37:822-834. 54.Reed DJ, Orrenius S: The role of methionine in glutathione biosynthesis by isolated hepatocytes. Biochem Biophys Res Commun 1977, 77:1257-1264. 55.Amores-Sanchez MI, Medina MA: Glutamine, as a precursor of glutathione, and oxidative stress. Molecular Genetics and Metabolism 1999, 67:100-105.
|